Profile data is unavailable for this security.
About the company
LePU Biopharma Co Ltd is a China-based biopharmaceutical company focused on tumor treatment. The Company mainly develops product lines of tumor candidate drugs, including antibody drug conjugate (ADC), oncolytic virus drug products and immunotherapy at clinical and pre-clinical stages. The Company’s major pipeline assets consist of MRG003, MRG002, HX008 and LP002, and three key clinical-stage drug candidates. The Company's products are sold at home and abroad.
- Revenue in HKD (TTM)243.02m
- Net income in HKD-23.83m
- Incorporated2018
- Employees429.00
- LocationLepu Biopharma Co LtdNo. 651Lianheng Road, Lianheng RoadSHANGHAI 201114ChinaCHN
- Phone+86 2 167696099
- Websitehttps://www.lepubiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.25m | 5.32bn | 2.87k | -- | 1.11 | -- | 2.65 | -0.0063 | -0.0063 | 0.2158 | 0.5123 | 0.1572 | 0.8101 | 4.72 | 698,606.10 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.46bn | 145.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
Consun Pharmaceutical Group Ltd | 2.79bn | 846.04m | 5.46bn | 3.13k | 6.31 | 1.39 | 5.86 | 1.96 | 1.06 | 1.06 | 3.50 | 4.82 | 0.4981 | 2.08 | 9.10 | 893,242.10 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.67m | 110.20m | 6.19bn | 948.00 | 19.61 | 0.8553 | -- | 7.09 | 0.1071 | 0.1071 | 0.8287 | 2.46 | 0.2852 | 1.44 | 1.62 | 920,541.00 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
Qyuns Therapeutics Co Ltd | 0.00 | -547.55m | 6.24bn | 331.00 | -- | 19.63 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
New Horizon Health Ltd | 1.47bn | 119.30m | 6.47bn | 1.04k | 59.24 | 2.01 | 41.66 | 4.41 | 0.2387 | 0.2387 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,672,843.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
Tong Ren Tang Technologies Co Ltd | 7.30bn | 636.46m | 7.04bn | 4.10k | 11.07 | 0.9482 | 5.15 | 0.9644 | 0.4969 | 0.4969 | 5.70 | 5.80 | 0.5212 | 0.9835 | 5.68 | 1,781,144.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 7.41bn | 3.44k | 6.47 | 0.9768 | 6.05 | 1.52 | 1.38 | 1.38 | 6.45 | 9.17 | 0.5073 | 1.44 | 6.31 | 1,417,524.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
Lepu Biopharma Co Ltd | 243.02m | -23.83m | 7.43bn | 429.00 | -- | 7.69 | 95.58 | 30.59 | -0.0144 | -0.0144 | 0.1465 | 0.5829 | 0.0917 | 1.06 | 1.62 | 566,476.80 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
Everest Medicines Ltd | 135.80m | -910.67m | 7.48bn | 432.00 | -- | 1.37 | -- | 55.11 | -2.91 | -2.91 | 0.4338 | 16.78 | 0.0203 | 2.25 | 4.57 | 314,362.20 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 8.09bn | 798.00 | 14.98 | 2.09 | 12.03 | 5.31 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 8.82bn | 4.62k | 4.10 | 1.03 | 3.64 | 1.30 | 2.44 | 2.44 | 7.71 | 9.72 | 0.5111 | 3.62 | 4.09 | 1,469,912.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 8.94bn | 1.62k | -- | 2.28 | -- | 6.98 | -1.16 | -1.16 | 1.06 | 3.24 | -- | -- | -- | 788,522.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
InnoCare Pharma Ltd | 796.43m | -680.75m | 9.00bn | 1.09k | -- | 1.05 | -- | 11.30 | -0.4036 | -0.4036 | 0.472 | 4.37 | 0.073 | 1.39 | 3.39 | 731,345.10 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
Cansino Biologics Inc | 372.24m | -1.60bn | 9.26bn | 1.49k | -- | 0.9577 | -- | 24.87 | -6.48 | -6.48 | 1.51 | 23.02 | 0.0332 | 2.37 | 0.4619 | 249,158.40 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
Data as of May 27 2024. Currency figures normalised to Lepu Biopharma Co Ltd's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
China Asset Management Co., Ltd.as of 31 Dec 2023 | 5.93m | 0.37% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 4.12m | 0.26% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.66m | 0.17% |
BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 1.09m | 0.07% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 855.00k | 0.05% |
BlackRock Fund Advisorsas of 09 May 2024 | 558.00k | 0.04% |
SSgA Funds Management, Inc.as of 09 May 2024 | 544.00k | 0.03% |
China Asset Management (Hong Kong) Ltd.as of 30 Apr 2024 | 543.96k | 0.03% |
TIAA-CREF Investment Management LLCas of 31 Mar 2024 | 469.00k | 0.03% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 385.00k | 0.02% |
More ▼
Data from 31 Dec 2023 - 22 May 2024Source: FactSet Research Systems Inc.